Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia
Ettore Lignelli, Francesco Palumbo, Despoina Myti, et al.
AJP Lung Cellular and Molecular Physiology (2019) Vol. 317, Iss. 6, pp. L832-L887
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Pulmonary hypertension in bronchopulmonary dysplasia
Georg Hansmann, Hannes Sallmon, Charles Christoph Roehr, et al.
Pediatric Research (2020) Vol. 89, Iss. 3, pp. 446-455
Open Access | Times Cited: 154
MSC Based Therapies—New Perspectives for the Injured Lung
Judith Behnke, Sarah Kremer, Tayyab Shahzad, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 682-682
Open Access | Times Cited: 152
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
Song Zhidu, Tao Ying, Rui Jiang, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies
Kiersten Giusto, Heather Wanczyk, Todd Jensen, et al.
Disease Models & Mechanisms (2021) Vol. 14, Iss. 2
Open Access | Times Cited: 59
Group 3 Pulmonary Hypertension: From Bench to Bedside
Navneet Singh, Peter Dorfmüller, Oksana A. Shlobin, et al.
Circulation Research (2022) Vol. 130, Iss. 9, pp. 1404-1422
Open Access | Times Cited: 46
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 45
The lung mesenchyme in development, regeneration, and fibrosis
Elie El Agha, Victor J. Thannickal
Journal of Clinical Investigation (2023) Vol. 133, Iss. 14
Open Access | Times Cited: 29
Bronchopulmonary dysplasia: what are its links to COPD?
Sharon A. McGrath‐Morrow, Joseph M. Collaco
Therapeutic Advances in Respiratory Disease (2019) Vol. 13, pp. 175346661989249-175346661989249
Open Access | Times Cited: 69
Bronchopulmonary dysplasia
Alexander R. Schmidt, Chandra Ramamoorthy
Pediatric Anesthesia (2021) Vol. 32, Iss. 2, pp. 174-180
Closed Access | Times Cited: 55
Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia
Andrea Porzionato, Patrizia Zaramella, Arben Dedja, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 320, Iss. 5, pp. L688-L704
Closed Access | Times Cited: 42
The Role of Nutrition in the Prevention and Management of Bronchopulmonary Dysplasia: A Literature Review and Clinical Approach
Gustavo Rocha, Hercília Guimarães, Luís Pereira‐da‐Silva
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 12, pp. 6245-6245
Open Access | Times Cited: 42
When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia
Lena Holzfurtner, Tayyab Shahzad, Ying Dong, et al.
Molecular and Cellular Pediatrics (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Postnatal Sepsis and Bronchopulmonary Dysplasia in Premature Infants: Mechanistic Insights into “New BPD”
Umar Salimi, Krishna Dummula, Megan H. Tucker, et al.
American Journal of Respiratory Cell and Molecular Biology (2021) Vol. 66, Iss. 2, pp. 137-145
Open Access | Times Cited: 40
Organoid models: assessing lung cell fate decisions and disease responses
Derek C. Liberti, Edward E. Morrisey
Trends in Molecular Medicine (2021) Vol. 27, Iss. 12, pp. 1159-1174
Closed Access | Times Cited: 39
Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
Ailin Yang, Yanjun Wu, Ganggang Yu, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Understanding the preterm human heart: What do we know so far?
Art Schuermans, Adam J. Lewandowski
The Anatomical Record (2022) Vol. 305, Iss. 9, pp. 2099-2112
Open Access | Times Cited: 26
A cell‐centric view of lung alveologenesis
Lisandra Vila Ellis, Jichao Chen
Developmental Dynamics (2020) Vol. 250, Iss. 4, pp. 482-496
Open Access | Times Cited: 36
Pulmonary hypertension in the child with bronchopulmonary dysplasia
Kelsey W. Malloy, Eric D. Austin
Pediatric Pulmonology (2021) Vol. 56, Iss. 11, pp. 3546-3556
Open Access | Times Cited: 32
Revisiting Airflow and Aerosol Transport Phenomena in the Deep Lungs with Microfluidics
Josué Sznitman
Chemical Reviews (2021) Vol. 122, Iss. 7, pp. 7182-7204
Open Access | Times Cited: 29
GSDMD deficiency ameliorates hyperoxia-induced BPD and ROP in neonatal mice
Sarah Sonny, Huijun Yuan, Shaoyi Chen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Lactobacillus plantarum L168 improves hyperoxia-induced pulmonary inflammation and hypoalveolarization in a rat model of bronchopulmonary dysplasia
Xian Shen, Zhaocong Yang, Qiang Wang, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Cyclin G1 Regulates the Alveolarization in Models of Bronchopulmonary Dysplasia by Inhibiting AT2 Cell Proliferation
Panpan Xu, Wanqing Zhuo, Peipei Zhang, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 101-101
Open Access
Preterm Infants With Bronchopulmonary Dysplasia and Pulmonary Hypertension
Kathryn Hasselfeld, Erik B. Hysinger, Melissa House
NeoReviews (2025) Vol. 26, Iss. 2, pp. e132-e140
Closed Access
Celastrol has beneficial effects on pulmonary hypertension associated with bronchopulmonary dysplasia: Preclinical study outcomes
Claire-Marie Pilard, Guillaume Cardouat, Isabel Gauthereau, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117881-117881
Open Access
Page 1 - Next Page

Scroll to top